Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nightly captopril for orthostatic intolerance in spinal cord injury
ACTRN12613001021763Phase 4Terminated
- Sponsor
- Austin Hospital
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of captopril in orthostatic intolerance and hypotension (2 arms), sponsored by Austin Hospital. Primary endpoint: Mean daytime blood pressure. Started Aug 2013; status: terminated.
02
Drugs
captopril
03
Conditions
orthostatic intolerancehypotension
Beyond the preview
Go deeper on ACTRN12613001021763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001021763.